Novo CEO pressed by Senate to cut selling prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would look at new talks with insurers in regards to the record prices of Wegovy and copyright if they pledge to help keep the medicines on their own https://dave-s-hot-chicken-nutrit31739.diowebhost.com/85713066/not-known-factual-statements-about-healthcare-news